Fintel reports that on February 6, 2025, HC Wainwright & Co. initiated coverage of Harrow (NasdaqGM:HROW) with a Buy ...

Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. A number of other ...

H.C. Wainwright analyst Heiko Ihle reiterated a Buy rating on Gold Royalty (GROY – Research Report) today and set a price target of $5.75. The ...

H.C. Wainwright raised the firm’s price target on Kura Oncology (KURA) to $40 from $37 and keeps a Buy rating on the shares. The firm says the ...

Northern Dynasty Minerals (NYSEAMERICAN:NAK – Get Free Report) (TSE:NDM)‘s stock had its “buy” rating restated by analysts at ...

H.C. Wainwright initiated coverage on Harrow Health (NASDAQ:HROW) with a Buy rating and set a price target of $57.00. According to InvestingPro data, this target represents significant upside ...

Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings H.C. Wainwright & Co., LLC, announced its #1 Ranking ...

We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...

In 2024 H.C. Wainwright also held the top position in PlacementTracker's Market League Tables for At-the-Market (ATM) Offerings representing 72 transactions. In addition to presently serving as ...

NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume for the calendar year of 2024, maintaining the Firm’s top position for 11 consecutive years ...

Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings NEW YORK, January 27, 2025--(BUSINESS WIRE)--H.C.